VENTURE CAPITAL FIRM
USING DATA SCIENCE
TO IDENTIFY DISRUPTIVE STARTUPS
Proprietary analytics to identify future market leaders.
Specialized capabilities for large, strategic investors.
VISION
We’re Changing the Way Large Organizations Think About Venture Capital
CORPORATE VENTURE CAPITAL IS EASY TO DO POORLY, BUT HARD TO DO WELL
Corporate venture capital (CVC) now accounts for around 45% of all venture investment. However most CVC efforts fail to deliver strong strategic or financial outcomes, resulting in average lifespans of only 4 years.
Decades of persistent CVC underperformance is not a case of bad luck or weak management. It has deeper root causes that are deceptively counter-intuitive. In other words, without specialized intervention CVC efforts are likely to fail for reasons that are both consistent and predictable.
Through its unique capabilities and technologies, Growth Science is redefining CVC for large, high profile strategic investors to more consistently deliver impactful strategic and financial results.
WHY GROWTH SCIENCE?
MORE DATA, LESS EGO
Growth Science was founded on the idea that nobody can really guess if a new business will succeed or fail.
As a result, Growth Science augments human intelligence through advanced computing, big data and statistics to create unprecedented visibility into the hidden structures and behavior of private markets.
Through this process, Growth Science is empowering its investors, startups and R&D collaborators to more consistently deliver innovative growth.
What is "growth science"?
Growth science is the study of how and why some companies, products or services experience rapid growth while others do not. It is an interdisciplinary field that combines elements of data science, psychology, economics and business strategy to understand and quantify the factors that contribute to a company's success.
Researchers in growth science use data and experimentation to identify and test hypotheses about what drives growth and to develop quantitatively robust strategies for companies to replicate that success.
COLLABORATION
None Of Us Is As Smart As All Of Us
For a decade and a half Growth Science has evolved its capabilities and proprietary analytics infrastructure through research collaborations with more than 50 market-leading multinational companies.
These collaborations span more than 1,000 market segments, crossing value chains as diverse as:
-
Raw materials,
-
Chemistry and material science,
-
Food and agriculture,
-
Building materials, real estate and construction
-
Insurance and financial services
-
Semiconductor, technology hardware and software
-
Healthcare diagnostics, therapeutics, medical devices and pharmaceuticals
-
Consumer products and services
CURRENT PORTFOLIOS
AGRITECH
DIAGNOSTICS
MULTI-INDUSTRY
